HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Construction of an attenuated Salmonella enterica serovar Paratyphi A vaccine strain harboring defined mutations in htrA and yncD.

Abstract
The global epidemic features of enteric fever have changed greatly in recent years. The incidence of enteric fever caused by Salmonella enterica serovar Paratyphi A has progressively increased. In some areas of Asia, infections with S. Paratyphi A have exceeded those with S. Typhi, resulting in S. Paratyphi A becoming the main causative agent of enteric fever. However, two currently licensed typhoid vaccines do not confer adequate cross-protection against S. Paratyphi A infection. Therefore, development of specific vaccines against enteric fever caused by S. Paratyphi A is urgently needed. In the present study, an attenuated strain was constructed by double deletion of the htrA and yncD genes in a wild-type strain of S. Paratyphi A and its safety and immunogenicity assessed. In a mouse model, the 50% lethal dose of the double deletion mutant and the wild-type strain were 3.0 × 10(8) CFU and 1.9 × 10(3) CFU, respectively, suggesting that the double deletion resulted in remarkably decreased bacterial virulence. Bacterial colonization of the double deletion mutant in the livers and spleens of infected mice was strikingly less than that of the wild-type strain. A single nasal administration of the attenuated vaccine candidate elicited high concentrations of anti-LPS and anti-flagellin IgG in a mouse model and protected immunized mice against lethal challenge with the wild-type strain. Thus, our findings suggest that the attenuated vaccine strain is a promising candidate worthy of further evaluation both as a human enteric fever vaccine and as a vaccine delivery vector for heterologous antigens.
AuthorsChunyue Zhu, Kun Xiong, Zhijin Chen, Xiaomei Hu, Jianhua Li, Yiran Wang, Xiancai Rao, Yanguang Cong
JournalMicrobiology and immunology (Microbiol Immunol) Vol. 59 Issue 8 Pg. 443-51 (Aug 2015) ISSN: 1348-0421 [Electronic] Australia
PMID26084199 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2015 The Societies and Wiley Publishing Asia Pty Ltd.
Chemical References
  • Antibodies, Bacterial
  • Immunoglobulin G
  • Lipopolysaccharides
  • Typhoid-Paratyphoid Vaccines
  • Vaccines, Attenuated
  • Virulence Factors
  • Flagellin
Topics
  • Administration, Intranasal
  • Animals
  • Antibodies, Bacterial (blood)
  • Bacterial Load
  • Disease Models, Animal
  • Female
  • Flagellin (immunology)
  • Gene Deletion
  • Immunoglobulin G (blood)
  • Lethal Dose 50
  • Lipopolysaccharides (immunology)
  • Liver (microbiology)
  • Mice, Inbred BALB C
  • Paratyphoid Fever (immunology, microbiology, prevention & control)
  • Salmonella paratyphi A (genetics, growth & development, immunology)
  • Spleen (microbiology)
  • Survival Analysis
  • Typhoid-Paratyphoid Vaccines (administration & dosage, genetics, immunology, isolation & purification)
  • Vaccines, Attenuated (administration & dosage, genetics, immunology, isolation & purification)
  • Virulence
  • Virulence Factors (deficiency)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: